Loading...
Loading...
Dan Nathan said on CNBC's "Options Action" that put volume was really high in SPDR S&P Biotech (ETF) XBI on Thursday. Puts outnumbered calls 3 to 1 as there were several large trades.
When the stock was trading at $74.65, there was a buyer of 10,000 contracts of the September 74/68 put spreads. The trader paid $1.67 for them, which sets the break even for the trade at $72.33 at the September expiration. The trade is going to reach its maximal profit of $4.33, if the stock drops to $68 or lower.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in